During the past decade, IMSP Mother and Child Institute conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "IMSP Mother and Child Institute" are "Severe Hemophilia A" (1 trials) and "Von Willebrand Disease" (1 trials). Many other conditions were trialed in "IMSP Mother and Child Institute" in a lesser frequency.

Most popular intervention types in "IMSP Mother and Child Institute" are "Biological" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Human-cl rhFVIII" (1 trials) and "wilate" (1 trials). Other intervention names were less common.

The vast majority of trials in "IMSP Mother and Child Institute" are 1 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "IMSP Mother and Child Institute". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in IMSP Mother and Child Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in IMSP Mother and Child Institute, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".